市场调查报告书
商品编码
1465100
栓塞预防设备市场:按设备类型、应用程式和最终用户划分 - 2024-2030 年全球预测Embolic Protection Devices Market by Device Type (Distal Filters, Distal Occlusion Devices, Proximal Occlusion Devices), Application (Cardiovascular Procedures, Neurovascular Procedures), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年栓塞预防设备市场规模为17.2亿美元,预计2024年将达18.6亿美元,2030年将达到29.8亿美元,复合年增长率为8.11%。
栓塞保护装置 (EPD) 是各种血管手术过程中使用的重要工具,用于捕获和清除可能鬆动并进入血液并导致身体其他部位(例如大脑)阻塞的碎片。由于全球心臟相关疾病的增加,对 EPD 的需求不断增加。 EPD 的部署将会增加,因为老年人口和老年人患病的风险更高,需要使用 EPD 进行干预。政府努力提高人们对心臟健康的认识,这增加了对 EPD 的需求,因为更频繁地诊断出血管疾病意味着需要更多的干预措施。新兴国家医疗保健设施和可近性的改善为 EPD 的采用提供了有利的框架。某些栓塞防护装置的产品召回引发了人们对 EPD 安全性、可靠性和有效性的担忧。此外,某些 EPD 并不适合所有导管尺寸或类型,且 EPD 部署的复杂性可能会增加手术併发症的风险。开发更简单、更通用的 EPD 可以解决适用性和部署问题,并提高 EPD 的效用。有利的政府政策和对环保署的迅速监管核准刺激了市场成长。
主要市场统计 | |
---|---|
基准年[2023] | 17.2亿美元 |
预测年份 [2024] | 18.6亿美元 |
预测年份 [2030] | 29.8亿美元 |
复合年增长率(%) | 8.11% |
设备类型弹性、有效性和微创性增加了远端过滤器的采用
远端过滤器是一种小型篮状装置,放置在血管内治疗部位之外。其主要功能是捕获和清除手术过程中可能释放到血液中的碎片。这些过滤器的设计目的是让血液流过,同时捕获足够大的颗粒,如果它们进入较小的血管,就会造成阻塞和损坏。手术完成后,小心地取出远端过滤器和任何截留的碎片。远端过滤器广泛用于涉及颈动脉和其他血管的干预措施,其中预防栓塞很重要。远端阻塞设备的工作原理是暂时阻止治疗区域远端(或之外)的血流。这种预防策略可防止栓塞颗粒向下游移动。该装置通常由气球或其他装置组成,可以在手术过程中充气以闭塞血管。在血流恢復之前,透过抽吸(抽吸)清除产生的任何碎片。这些装置在捕获所有潜在碎片非常重要的情况下特别有用,并且与其他方法结合使用以确保在恢復正常血流之前彻底清洗血液通常组合使用。近端阻塞设备暂时阻止治疗部位附近(或之前)的血流。这是透过将阻塞设备放置在比治疗部位更靠近心臟的位置来实现的,以防止碎片脱落并流向大脑或其他重要器官。在许多情况下,气球被充气以闭塞血管。近端阻塞设备的主要优点是它们可以防止栓塞颗粒进入治疗部位,从而提供预防性保护。
应用范例 管理大容量介入心臟病学和手术的栓塞预防设备的需求不断增长
栓塞防护装置主要用于心臟和动脉介入治疗,例如经皮冠状动脉介入治疗 (PCI)、颈动脉置入术和经导管主动脉瓣置换术(TAVR)。在这些手术过程中,栓塞碎片脱落并在血流中移动的风险很大。栓塞碎片会阻塞通往心臟和大脑的血管,造成潜在的严重后果。因此,部署栓塞防护装置来捕捉这些碎片并确保手术的安全性和有效性。使用栓塞保护装置已成为标准治疗的一部分,以尽量减少中风和其他併发症的风险。神经血管手术涉及治疗大脑内或与大脑相连的血管。在这种情况下,栓塞保护装置用于透过捕获在颅内或颅外动脉置入术或血管成形术等手术过程中可能释放的碎片来预防中风。儘管这些设备在神经血管手术中的使用越来越多,但由于脑血管的解剖结构微妙而复杂,它们提出了独特的挑战。重点是防止因血栓和碎片阻碍血液流向大脑而引起的栓塞性中风。
区域洞察
以美国和加拿大为中心的美洲地区凭藉强大的医疗设备,在栓塞预防器材市场中占有重要地位。美国的患者和医疗保健专业人员正在强调品质和有效性的重要性,这正在影响他们对更先进、更可靠的设备的购买行为。该地区也以其强大的研发活动而闻名,许多专利来自新兴国家。在欧盟 (EU) 国家,由于人口老化和心血管疾病预防意识的增强,对栓塞防护装置的需求不断增加。欧盟严格的法规环境确保只有符合高安全性和有效性标准的设备才能投放市场,且消费者的购买决策受到可靠且经过临床检验的设备的影响。 Horizon Europe 计画等倡议支持研究和创新,包括医疗设备领域的研究和创新,并可以促进新的栓塞防护技术的开发。由于政府对改善医疗基础设施的大力支持以及对心血管疾病意识的稳定提高,亚太地区是栓塞防护设备成长最快的市场。这些国家的投资和专利主要用于开发具有成本效益和高效的设备,以满足当地需求。
FPNV定位矩阵
FPNV 定位矩阵对于评估栓塞预防设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对栓塞预防设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.栓塞预防器材市场规模及预测是多少?
2.在栓塞预防设备市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.栓塞预防器材市场的技术趋势和法规结构是什么?
4.栓塞预防设备市场主要供应商的市场占有率为何?
5. 进入栓塞预防器材市场的适当型态和策略手段是什么?
[180 Pages Report] The Embolic Protection Devices Market size was estimated at USD 1.72 billion in 2023 and expected to reach USD 1.86 billion in 2024, at a CAGR 8.11% to reach USD 2.98 billion by 2030.
Embolic protection devices (EPDs) are critical tools used during various vascular procedures to capture and remove debris that might become loose and enter the bloodstream, potentially causing blockages elsewhere in the body, such as the brain. An increase in heart-related conditions globally drives the need for EPDs, as they are often used in procedures addressing these issues. Older populations and senior citizens are at a higher risk for diseases requiring interventions that use EPDs, thus increasing the deployment of EPDs. More frequent diagnosis of vascular conditions leads to a higher number of interventions, and government initiatives to raise awareness for heart health have led to a higher need for EPDs. Improved healthcare facilities and access in emerging economies provide a conducive framework for the adoption of EPDs. Incidences of product recall of certain embolic protection devices raise concerns about the safety, reliability, and efficacy of EPDs. Moreover, some EPDs may not be compatible with all catheter sizes or types, and the complexity of deploying EPDs can increase the risk of procedural complications. Developing simpler, more versatile EPDs can address compatibility and deployment issues, increasing their utility. Favorable government policies and quicker regulatory approvals for EPDs stimulate market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.72 billion |
Estimated Year [2024] | USD 1.86 billion |
Forecast Year [2030] | USD 2.98 billion |
CAGR (%) | 8.11% |
Device Type: Emerging adoption of distal filters owing to their flexibility, effectiveness, and minimally invasive nature
Distal filters are small, basket-like devices placed beyond the treatment site in the blood vessel. Their primary function is to capture and remove debris that may be released into the bloodstream during a procedure. These filters are designed to allow blood to flow through while trapping particles large enough to cause blockages or damage if they were to travel to smaller vessels. After the procedure is complete, the distal filter and captured debris are carefully retrieved. Distal filters are widely used in interventions involving the carotid arteries and other vessels where preventing embolism is critical. Distal occlusion devices work by temporarily blocking the blood flow distal to (or beyond) the treatment site. This prevention strategy stops embolic particles from traveling downstream. The device typically consists of a balloon or another mechanism that can be inflated to occlude the vessel during the procedure. Any debris generated is then removed by aspiration (suction) before the blood flow is restored. These devices are particularly useful in situations where capturing all potential debris is crucial, and they are often used in conjunction with other methods to ensure thorough cleaning of the blood before normal flow is resumed. Proximal occlusion devices temporarily halt blood flow proximal to (or before) the treatment area. This is achieved by placing the occlusion device closer to the heart than the site of the procedure, which prevents any debris from being dislodged and traveling toward the brain or other critical organs. They often involve a balloon mechanism that can be inflated to block the vessel. The main advantage of proximal occlusion devices is that they prevent embolic particles from even entering the area being treated, offering a proactive form of protection.
Application: Expanding need for embolic protection devices to manage the large volume of cardiovascular interventions and surgeries
In cardiovascular procedures, embolic protection devices are predominantly used during interventions involving the heart and arteries, such as percutaneous coronary interventions (PCI), carotid artery stenting, and transcatheter aortic valve replacement (TAVR). During these procedures, the risk of embolic debris dislodging and traveling through the bloodstream is significant. The debris could potentially block blood vessels leading to the heart or brain, resulting in severe consequences. Therefore, embolic protection devices are deployed to catch this debris, ensuring the safety and effectiveness of the procedure. Their use has become a standard part of practices aimed at minimizing the risk of stroke and other complications during these interventions. Neurovascular procedures involve treatments of the blood vessels within the brain or those leading to the brain. Embolic protection devices in this context are used to prevent strokes by capturing debris that might be released during procedures such as stenting or angioplasty of intracranial or extracranial arteries. While the use of these devices in neurovascular procedures is growing, they pose unique challenges due to the delicate and complex nature of the brain's vascular anatomy. The emphasis is on protecting against embolic strokes, which are caused by blood clots or debris blocking blood flow to the brain.
Regional Insights
The Americas region, particularly the United States and Canada, shows a prominent presence in the embolic protection devices market, driven by its robust healthcare infrastructure and favorable regulatory support for medical device authorization. Patients and healthcare professionals in the U.S. emphasize the importance of quality and efficacy, influencing purchasing behavior towards more advanced and reliable devices. The region is also known for significant research and development activities, with numerous patents related to embolic protection devices originating from these countries. European Union (EU) countries demonstrate a strong need for embolic protection devices owing to the presence of an aging population and increasing awareness of cardiovascular disease prevention. The EU's stringent regulatory environment ensures that only devices that meet high safety and effectiveness standards reach the market, affecting consumer purchasing decisions toward trusted and clinically validated devices. Initiatives such as the Horizon Europe program support research and innovation, including in the medical device sector, which could lead to the development of new embolic protection technologies. APAC region showcases a rapidly growing market for embolic protection devices, owing to robust government support for improving the healthcare infrastructure and steadily increasing awareness for cardiovascular conditions. Investments and patents in these countries are primarily focused on developing cost-effective and efficient devices to meet local needs.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Embolic Protection Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Embolic Protection Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Embolic Protection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Balton Sp. z o. o., Boston Scientific Corporation, Contego Medical, Inc., Cook Group Incorporated, Cordis, Edwards Lifesciences Corporation, Emboline, Inc., Filterlex Medical Ltd., Inari Medical, Inc., InspireMD Inc., Invamed, Keystone Heart US, Inc. by Venus Medtech (Hangzhou) Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, NIPRO CORPORATION, Penumbra, Inc., Protembis GmbH, Silk Road Medical, Inc., Stryker Corporation, Terumo Medical Corporation, Transverse Medical Inc., and W. L. Gore & Associates, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Embolic Protection Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Embolic Protection Devices Market?
3. What are the technology trends and regulatory frameworks in the Embolic Protection Devices Market?
4. What is the market share of the leading vendors in the Embolic Protection Devices Market?
5. Which modes and strategic moves are suitable for entering the Embolic Protection Devices Market?